quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:26·969d
SECFiling
Nautilus Inc. logo

SEC Form EFFECT filed by Nautilus Inc.

NLS· Nautilus Inc.
Consumer Discretionary
Original source

Companies

  • NLS
    Nautilus Inc.
    Consumer Discretionary

Recent analyst ratings

  • Feb 10UpdateCraig-Hallum$9.00
  • Aug 10UpdateRoth Capital$12.50
  • Aug 10UpdateCraig Hallum-

Related

  • PR175d
    NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
  • INSIDER799d
    Ross Patricia M. was granted 26,515 shares, increasing direct ownership by 63% to 68,675 units (SEC Form 4)
  • SEC799d
    SEC Form NT 10-Q filed by Nautilus Inc.
  • SEC808d
    Nautilus Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • SEC874d
    Nautilus Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
  • 13D/G899d
    SEC Form SC 13D filed by Nautilus Inc.
  • NEWS905d
    Nautilus, Inc. Rebrands As BowFlex Inc.
  • PR905d
    Nautilus, Inc. Rebrands as BowFlex Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022